Memphasys Limited (ASX:MEM)
0.0050
0.00 (0.00%)
Oct 9, 2026, 3:53 PM AEST
Memphasys Market Cap
Memphasys has a market cap or net worth of 15.44 million as of October 9, 2026. It is the 41,241st most valuable company in the world and the 1,192nd biggest in Australia. Its market cap has increased by 72.19% in one year.
Market Cap
15.44M
Enterprise Value
18.50M
Revenue
657.97K
Global Rank
Country Rank
#1,192 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since May 14, 2007, Memphasys's market cap has increased from 5.33M to 15.44M, an increase of 189.69%. That is a compound annual growth rate of 5.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 15.44M | -17.94% |
| Dec 31, 2025 | 18.81M | 32.77% |
| Dec 31, 2024 | 14.17M | 4.43% |
| Dec 29, 2023 | 13.57M | 1.01% |
| Dec 30, 2022 | 13.43M | -81.77% |
| Dec 31, 2021 | 73.67M | -2.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Micro-X | 48.16M |
| Cleo Diagnostics | 43.88M |
| HeraMED | 42.87M |
| CleanSpace Holdings | 39.68M |
| Nova Eye Medical | 37.61M |
| Control Bionics | 35.30M |
| OncoSil Medical | 26.43M |
| ImpediMed | 21.97M |